<html>
<head>PUBMED IDs for CBR3</head>
<body bgcolor='#C5F0F2'><h1>CBR3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9740676/'>Mapping of a novel human carbonyl reductase, CBR3, and ribosomal pseudogenes to human chromosome 21q22.2.</a> September 19  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10950924/'>C21orf5, a novel human chromosome 21 gene, has a Caenorhabditis elegans ortholog (pad-1) required for embryonic patterning.</a> August 22  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11082196/'>Cloning and bacterial expression of monomeric short-chain dehydrogenase/reductase (carbonyl reductase) from CHO-K1 cells.</a> November 18  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/12604224/'>Further characterization of Chinese hamster carbonyl reductases (CHCRs).</a> February 27  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14561749/'>PTEN M-CBR3, a versatile and selective regulator of inositol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P5). Evidence for Ins(1,3,4,5,6)P5 as a proliferative signal.</a> October 17  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15537833/'>Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3).</a> November 13  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/17270157/'>Sepiapterin reductase expression is increased in Parkinson's disease brain tissue.</a> February 3  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18457324/'>Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer.</a> May 7  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18477249/'>Identification of candidate genes involved in the radiosensitivity of esophageal cancer cells by microarray analysis.</a> May 15  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18493841/'>Different functions between human monomeric carbonyl reductase 3 and carbonyl reductase 1.</a> May 22  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18983987/'>Investigation of the role of the amino acid residue at position 230 for catalysis in monomeric carbonyl reductase 3.</a> November 6  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19016765/'>CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients.</a> November 20  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19088019/'>Pharmacogenetics in breast cancer therapy.</a> January 7  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19590938/'>Identification of the promoter of human carbonyl reductase 3 (CBR3) and impact of common promoter polymorphisms on hepatic CBR3 mRNA expression.</a> November 3  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20302569/'>Pharmacogenetics of target genes across doxorubicin disposition pathway: a review.</a> June 11  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20806931/'>Regulation of human carbonyl reductase 3 (CBR3; SDR21C2) expression by Nrf2 in cultured cancer cells.</a> January 28  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20806854/'>[Primary, study of miRNA expression patterns in laryngeal carcinoma by microarray].</a> July 19  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20806820/'>[EGFR tyrosine kinase inhibitors as a targeted therapy for bronchioloalveolar carcinoma of the lung: a case report of a clinically prompt and intensive response and literature review].</a> October 13  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20942781/'>Human carbonyl reductases.</a> April 13  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20942773/'>PLX4032: does it keep its promise for metastatic melanoma treatment?</a> April 22  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20942676/'>The origin of ovarian cancerâ€”is it getting clearer?</a> October 22  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20942669/'>ARID1A mutations in endometriosis-associated ovarian carcinomas.</a> October 22  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22001310/'>A conserved antioxidant response element (ARE) in the promoter of human carbonyl reductase 3 (CBR3) mediates induction by the master redox switch Nrf2.</a> January 21  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22425771/'>Expression of human carbonyl reductase 3 (CBR3; SDR21C2) is inducible by pro-inflammatory stimuli.</a> May 26  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22527884/'>Genetic variation in the carbonyl reductase 3 gene confers risk of type 2 diabetes and insulin resistance: a potential regulator of adipogenesis.</a> September 27  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23104507/'>Oxidative stress contributes to liver damage in a murine model of alpha-1-antitrypsin deficiency.</a> February 6  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23182048/'>The relationship between changes in functional cardiac parameters following anthracycline therapy and carbonyl reductase 3 and glutathione S transferase Pi polymorphisms.</a> May 7  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24292679/'>Mechanism of human PTEN localization revealed by heterologous expression in Dictyostelium.</a> February 26  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24798743/'>Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics.</a> April 2  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24798740/'>Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma.</a> April 1  2014<br></body></html>
